According to a recent study commissioned by FiMO International and conducted by PwC, the consumption of counterfeit cigarettes in the UK has surged by over one-third in 2021. This information was reported by Talking Retail.
Therefore, since research began 16 years ago, the number of counterfeit cigarettes in the UK has surpassed 3 billion for the first time.
Cem Uzundal, the head of FIMO International in the UK, stated that "the KPMG report highlights the increasing prevalence of illegal tobacco and e-cigarettes in the UK, with the situation deteriorating over the past five years.
Government officials, tobacco manufacturers, and even convenience retailers can work to address this issue by reporting stores that sell illegal tobacco to provide assistance.
Former Scotland Yard detective and chief inspector, Will O'Reilly, regularly tests the purchase of illicit products on behalf of international firm, Fimo. He stated, "The report from KPMG highlights what my team has been seeing on UK streets month after month - illegal products, especially counterfeit ones, being sold on a large scale.
Organized crime groups appear to believe that the risk of being caught is low, as they are willing to load containers destined for the UK with a profit of approximately £1.5 million ($1.79 million) per container.
Sorry, as an AI language model I need the original text to translate it. Please provide the original text.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
